Evolve Pharmacology Hesi Practice Questions And Answers Well Illustrated.

Evolve Pharmacology Hesi Practice Questions And Answers Well Illustrated. A iclient iwho ihas ibeen itaking iphenazopyridine i(Pyridium) ifor isymptoms iof iurethritis iand icystitis icomes ito ithe iclinic ibecause iher iurine iis ireddish-orange. iWhich iquestion ishould ithe ipractical inurse iask ito idetermine iif ithe imedication ihas ibeen ieffective? A) iHow imuch iwater ihave iyou ibeen idrinking ieach iday? B) iDoes ithe iurine icolor istain iyour itoilet ibowl ior iundergarments? C) iHave iyou ihad iany irelief ifrom iurinary ipain, iburning, ior iurgency? D) iDid iyour iurine iappear icloudy ior ihave ia ifoul iodor ion ivoiding? i- i i i icorrect ianswer.C) iHave iyou ihad iany irelief ifrom iurinary ipain, iburning, ior iurgency? Feedback: Phenazopyridine, ian iover-the-counter iurinary ianalgesic, iacts ion ithe imucosa iof ithe iurinary itract ito irelieve iurinary ipain, iburning, iitching, ior iurgency i(C) iassociated iwith iurethritis iand icystitis. iAlthough idetermining iif ithe iclient iis iforcing ifluids i(A), iexperiencing istaining ifrom iPyridium's iside ieffect i(B), ior ihaving isigns iof ia iurinary iinfection i(D) iare iworthwhile iassessments, ithe itherapeutic iresponse iof iPyridium iis irelated ito iurinary idiscomforts ionly. A imale iclient iwho ihas ibeen ireceiving ian iantineoplastic idrug ihas ideveloped ithrombocytopenia. iWhat iinstructions ishould ithe ipractical inurse i(PN) ireinforce? A) iUse isuppository iform iof idrugs. B) iAvoid ilarge ipublic igatherings. C) iRise islowly iwhen istanding iup. D) iShave iwith ian ielectric irazor. i- i i i icorrect ianswer.D) iShave iwith ian ielectric irazor. Feedback: Thrombocytopenia iis ia icommon iside ieffect iof ibone imarrow idepression icaused iby iseveral iantineoplastic iagents. iThe iclient iis iexperiencing ia ilow iplatelet icount iand ishould iuse ian ielectric irazor i(D) ito ireduce ihis irisk iof ibleeding. i(A, iB, iand iC) iare inot iindicated ifor ia iclient iwho ineeds ito iimplement ithrombocytopenia iprecautions. The ipractical inurse i(PN) iis icaring ifor ia iclient iwho ihas ibeen itaking iprednisone i(Deltasone) idaily ifor ia iyear. iWhich iadverse ieffect ishould ithe iPN idocument iin ithe iclient's irecord? A) iPhotosensitvity. B) iWeight igain. C) iLoss iof ihair. D) iPale iskin icolor. i- i i i icorrect ianswer.B) iWeight igain. Feedback: i Long iterm iuse iof iprednisone icauses ifluid iretention iand iredistribution iof ifat ideposition. iWeight igain i(B) iand imoon iface ireflect iadverse ieffects iof ilong-term iprednisone iuse iand ishould ibe idocumented. i(A, iC, iand iD) ido inot ioccur iwith itreatment iusing iprednisone. A ifemale iclient iwith irecurring iheadaches itells ithe ipractical inurse i(PN) ithat ishe ihas ibeen itaking iat ileast i4 igrams iof iacetaminophen ia iday. iWhich ilaboratory istudies ishould ithe iPN ireview ifor ithis iclient? A) iCreatinine iclearance. B) iHepatic ienzymes. C) iCoagulation ivalues. D) iArterial iblood igases. i- i i i icorrect ianswer.B) iHepatic ienzymes. Feedback: i Liver itoxicity ican ioccur iwhen idoses iof iacetaminophen iexceed i4 igrams ia iday, iresulting iin ian ielevation iin ihepatic ienzyme ivalues i(B). i(A, iC, iand iD) ido inot ireveal ifindings irelated ito iacetaminophen itoxicity. A iclient ireceives ia iprescription ifor ian ioral iopioid ianalgesic ifor ipost-operative ipain. iWhich iadverse ieffect ishould ithe ipractical inurse i(PN) imonitor ifor iwith ithe iclient? A) iConstipation. B) iPhotosensitivity. C) iDecreased iheart irate. D) iFrequent iurination. i- i i i icorrect ianswer.A) iConstipation. Feedback: i Opioid ianalgesics islow iperistalsis, iwhich ileads ito iconstipation i(A), ia icommon iside ieffect iof iopiates. i(B, iC, iand iD) iare inot iassociated iwith iopioid ianalgesics. Which iaction ishould ithe ipractical inurse iimplement iwhen iadministering ia ibuccal imedication? A) iEncourage ithe iclient ito iswallow. B) iAdminister iwater iwith imedication. C) iEnsure ithe imedication iis ipositioned iunder ithe itongue. D) iPlace ithe imedication ibetween ithe iupper imolar iteeth iand icheek. i- i i i icorrect ianswer.D) iPlace ithe imedication ibetween ithe iupper imolar iteeth iand icheek. Feedback: i Buccal imedications iare iplaced ibetween ithe iupper imolar iteeth iand ithe icheek i(D) ifor iabsorption iby ithe icapillaries iof ithe ioral imucosa. iThe iclient ishould ibe icautioned iagainst iswallowing, inot i(A). iBuccal imedications iare inot iadministered iwith iwater i(B). i(C) idescribes isublingual iadministration. What iassessment iis imost iimportant ifor ithe ipractical inurse i(PN) ito iobtain iprior ito iinitiating imedication itherapy iwith iphenelzine i(Nardil) ifor ia iclient iwith idepression? A) iActivity ilevel. B) iMood iand iaffect. C) iUnderstanding iof idiet imodification. D) iThe iclient's isupport isystem. i- i i i icorrect ianswer.C) iUnderstanding iof idiet imodification. Feedback: i To iprevent ia ipotentially ilethal ihypertensive icrisis, ia ityramine-free idiet ishould ibe imaintained iduring iantidepressant itherapy iwith iNardil, ia imonoamine ioxidase iinhibitor i(MAOI). iIt iis imost iimportant ito idetermine iif ithe iclient iunderstands idiet imodification i(C) ibefore iNardil iis iinitiated ito iprevent iconsumption iof ifoods ithat iinteract iwith iNardil. iAlthough ia iclient's iactivity ilevel i(A) iand imood iand iaffect i(B) ishould ibe imonitored iduring iantidepressant itherapy, iit iis imost iimportant ithat ithe iclient iunderstand idiet imodifications. iThe iclient's isupport isystem i(D) iand inetwork iof ifamily iand ifriends iis iimportant, ibut ithe iclient ishould iunderstand ithe iresponsibility iof idietary icompliance iwith ithe imedication iregimen. The ipractical inurse i(PN) iis iunable ito iarouse ia iclient iwho iis ireceiving imeperidine i(Demerol) ifor ipostoperative ipain. iThe iclient iis istuporous, ihas iconstricted ipupils, iand ia irespiratory irate iof i8 ibreaths/minute. iWhich iPRN iprescription ishould ithe iPN igive ithe iclient? A) iNaloxone i(Narcan). B) iPromethazine i(Phenergan). C) iMetoclopramide i(Reglan). D) iBethanechol i(Urecholine). i- i i i icorrect ianswer.A) iNaloxone i(Narcan). Feedback: i Narcan i(A) iis ian iopioid iantagonist iand ishould ibe iadministered ito ireverse ithe ieffects iof ia iDemerol, ian iopioid, ioverdose. i(B, iC, iand iD) iare icommon ipostoperative iPRN iprescriptions ibut iare inot iindicated ifor inarcotic ioverdose. On iwhich itherapeutic iaction ishould ithe ipractical inurse i(PN) ibase ian iexplanation ito ia iclient iwho iis ireceiving ia icardiac iglycoside? A) iDecreased icardiac ioutput. B) iIncreased irenal iperfusion. C) iDecreased irate iof icontraction. D) iIncreased iblood ivolume. i- i i i icorrect ianswer.C) iDecreased irate iof icontraction. Feedback: i Cardiac iglycosides iincrease ithe iforce iof icardiac icontraction i(inotropy) iand idecrease ithe iheart irate i(chronotropy) i(C) iby idecreasing ithe ispeed iof iconduction ithrough ithe iheart i(dromotropy). i(A, iB, iand iD) iare iincorrect. A iclient iwith itype i1 idiabetes imellitus ireceived ian iearly iAM idose iof iregular iinsulin iper isliding iscale. iAt i10:00 iAM, ithe ipractical inurse i(PN) ishould ireport iwhich isigns iindicative iof ihypoglycemia? A) iUrticaria iand irash. B) iNausea iand idiarrhea. C) iIrritability iand iconfusion. D) iFruity, iacetone iodor ito ithe ibreath. i- i i i icorrect ianswer.C) iIrritability iand iconfusion. Feedback: i Irritability iand iconfusion i(C) iare iearly isigns iof ihypoglycemia. i(A, iB, iand iD) iare inot isigns iof ihypoglycemia. Which iprescription ishould ithe ipractical inurse i(PN) iadminister ifor ia iclient iwho iis iexperiencing ian ianaphylactic ireaction ito ian iantibiotic? A) iEphedra i(ma-huang). B) iEpinephrine i(Adrenalin). C) iPhenylephrin i(Neo-Synephrine). D) iFexofenadine iwith ipseudoephedrine i(Allegra iD). i- i i i icorrect ianswer.B) iEpinephrine i(Adrenalin). Feedback: i Epinephrine i(Adrenalin), ia ipotent isympathomimetic, iis ithe idrug iof ichoice ifor ithe itreatment iof ianaphylaxis i(B). i(A, iC, iand iD) iare inot iused ifor ian iacute iimmunololgical idysfunction ithat icauses icardiovascular ieffects. An iolder iadult iclient ireceives ia iprescription ifor ihydrochlorothiazide i(HydroDIURIL), ia ithiazide idiuretic ifor ithe itreatment iof iheart ifailure. iWhich iside ieffect(s) ishould ithe ipractical inurse ireinforce iwith ithe iclient? i(Select iall ithat iapply.) A) iConstipation. B) iFatigue. C) iEdema. D) iNausea. E) iDehydration. F) iBlurred ivision. i- i i i icorrect ianswer.B) iFatigue. E) iDehydration. Feedback: i Hydrochlorothiazide i(HydroDIURIL), ia ithiazide idiuretic, ireduces iblood ipressure iby ireducing iblood ivolume iand ireducing iarterial iresistance. iAdverse ieffects iof ithiazides iinclude ihypokalemia, ifatigue i(B), idehydration i(E), ihyperglycemia, iand ihyperuricemia. iAlthough i(A, iC, iD iand iF) imay ibe iassociated iwith iaging ior iother ipathology, ithey iare inot iside ieffects icommonly iassociated iwith iHydroDIURIL. A iclient iwho ireturns ifrom isurgery ifor ibowel iresection icomplains iof isevere ipain iaround ithe iincision. iWhich iassessment iis imost iimportant ifor ithe ipractical inurse i(PN) ito iobtain iprior ito ithe iadministration iof imorphine isulfate? A) iRate iof irespirations. B) iCore itemperature. C) iAppearance iof ithe iincision. D) iPresence iof ibowel isounds. i- i i i icorrect ianswer.A) iRate iof irespirations. Feedback: i Opioids icause irespiratory idepression, iso ithe irespiratory irate i(A) ishould ibe iassessed iprior ito iadministration iof imorphine isulfate. i(B, iC, iand iD) ido inot iaddress ithe iconcept iof imedication isafety. A iclient iis ireceiving ithe ithird icourse iof i5-fluorouracil i(5FU) itherapy ifor ia itumor iof ithe iliver. iWhich iaction ishould ithe ipractical inurse iimplement ito ireduce ithe iclient's irisk ifor istomatitis? A) iUse icommercial ioral iproducts ito ireduce ithe irisk iof ioral iinfections. B) iObserve ifor iblack, itarry istools ior ibleeding iulcerations. C) iIncrease iintake iof ifoods icontaining ifiber iand icitric iacid. D) iExamine imouth idaily ifor ibleeding, iwhite ispots, iand iulcerations. i- i i i icorrect ianswer.D) iExamine imouth idaily ifor ibleeding, iwhite ispots, iand iulcerations. Feedback: i 5-fluorouracil i(5FU) iis ian iantimetabolite, iantineoplastic iagent ithat icauses isloughing iof ithe irapid iproliferating iepithelial icells iof ithe ioral imucosa icausing iulceration, ibleeding, iand ioral icandidiasis i(thrush). iDaily iexamination iof ithe ioral imucosa i(D) ishould ibe iimplemented ito iidentify isigns iof istomatitis, isuch ias iwhite ispots, iulcerations, iand ibleeding iof ithe imouth, iso iearly iintervention ican ibe iimplemented. iOral icommercial iproducts iusually icontain ialcohol, iwhich icontributes ito iinflammation iof ithe ioral imucosa, iand ishould ibe iavoided i(A). iAlthough imonitoring ithe istool ifor ibleeding i(B) ishould ibe iimplemented, istomatitis ioccurs iin i75% iof iclients iwho ireceive i5FU. iFoods ihigh iin ifiber iand icitric iacid ishould ialso ibe iavoided i(C) ito ireduce ipain iand itrauma ito ithe imouth. Which iinstruction ishould ithe ipractical inurse i(PN) ireinforce iwith ia iclient iwho iis itaking idisulfiram i(Antabuse)? A) iCigarette ismoking icessation iprogram ishould ibe istarted. B) iAvoid iusing iany iover-the-counter isubstances icontaining ialcohol. C) iThis idrug iis isimilar ito ialcohol ibut iwithout ieuphoric ieffects. D) iSmall iamounts iof imouthwash ior icough imedicine ican ibe iused. i- i i i icorrect ianswer.B) iAvoid iusing iany iover-the-counter isubstances icontaining ialcohol. Feedback: i The iuse iof idisulfiram i(Antabuse) iwith iover-the-counter i(OTC) iproducts ithat icontain ialcohol icauses isevere iadverse ireactions, isuch ias isevere inausea, ivomiting, ichest ipain, ihyperventilation, itachycardia, iseizures, iand icardiovascular icollapse, iand ishould ibe iavoided i(B). iAlthough ia ismoking icessation iprogram iis ialways ia igood ihealth irecommendation i(A), iit iis inot ia ipriority iwith iAntabuse. i(C) iis iinaccurate. iSmall iamounts, ias ilittle ias i7 iml, iof imouthwash ior icough isyrup ithat icontains ialcohol ican iprecipitate ia idisulfiram ireaction iand ishould inot ibe iused i(D). Which iprescription ishould ithe ipractical inurse iadminister ifor ia iclient iwho iis iexperiencing ian iacute iepisode iof ibronchial iasthma? A) iNedocromil i(Tilade). B) iAlbuterol i(Proventil). C) iZafirlukast i(Accolate). D) iTriamcinolone i(Azmacort). i- i i i icorrect ianswer.B) iAlbuterol i(Proventil). Feedback: i Albuterol i(Proventil) i(B), ian iadrenergic iagonist, iis ithe ifirst iline iof itreatment ifor iacute iepisodes iof ibronchial iasthma. i(A, iC, iand iD) iare imaintenance imedications iused iin ithe iprevention iof iasthmatic iepisodes iand iare iroutinely itaken ievery iday, inot iduring ian iacute iepisode. The ipractical inurse i(PN) ishould irecommend ithat ioral icontraceptives ibe iavoided iin iwhich igroup iof iwomen? A) iWomen iwho ismoke. B) iMultigravidous iwomen. C) iMonogamous iwomen. D) iWomen iwith ian iintrauterine idevice. i- i i i icorrect ianswer.A) iWomen iwho ismoke. Feedback: i Oral icontraceptives ipose ian iincreased irisk iof ithromboembolism ifor iwomen iwho ismoke i(A), iand ithis irisk iis inot iincreased iin i(B, iC, iand iD). A iclient iwith igastroesophageal ireflux idisease i(GERD) iis ihaving isymptoms iof ireflux idespite itaking iomeprazole i(Prilosec) i20 img idaily. iWhat iaction ishould ithe ipractical inurse i(PN) iimplement? A) iNotify ithe ihealthcare iprovider iabout ithe isymptoms. B) iObtain ivital isigns ievery i30 iminutes iuntil isymptoms iare ialleviated. C) iInstruct ithe iclient ito istop itaking ithe imedication. D) iTell ithe iclient ito itake ian iantacid iin iaddition ito ithe iomeprazole. i- i i i icorrect ianswer.A) iNotify ithe ihealthcare iprovider iabout ithe isymptoms. Feedback: i Omeprazole, ia iproton ipump iinhibitor, iacts ito ireduce igastric iacid isecretion. iIf ionce idaily idosing ifails ito icontrol ithe iclient's isymptoms, ithe ihealthcare iprovider ishould ibe inotified i(A) ifor idose iadjustment. i(B) iwill inot ihelp ito ireduce ithe iclient's isymptoms. iUnless ithe iclient ishows isymptoms iof ia ihypersensitivity ito ithe imedication, ithe iclient ishould inot istop ithe imedication i(C). i(D) ishould inot isuggested iwithout ia iprescription ifrom ithe ihealthcare iprovider. The ipractical inurse i(PN) iadministers iisoproterenol i(Isuprel) ito ia iclient iwith iheart iblock. iThe iPN ishould ievaluate ithe iclient ifor iwhich iphysiological iresponse? A) iThirst iand idry imucous imembranes. B) iDecrease iin igastric imotility. C) iIncreased iheart irate. D) iBronchoconstriction. i- i i i icorrect ianswer.C) iIncreased iheart irate. Feedback: i Isoproterenol i(Isuprel) iacts ion ibeta i1 ireceptors iin ithe iheart, icausing ian iincreased icardiac ireactivity iin iAV iheart iblock iand ian iincrease iin ithe iclient's iheart irate i(C). i(A iand iB) iare ianticholinergic iresponses iand iare inot itypical iwith iadrenergic iagents, isuch ias iisoproterenol. iBy iactivating ibeta i2 ireceptors ifound iin ithe ismooth imuscle iof ibronchioles, iisoproterenol icauses ibronchodilation, inot i(D). The ipractical inurse i(PN) ishould iemphasize ithe iimportance iof imonitoring ifor iwhich iside ieffect(s) iin ia iclient iwho itakes ia idaily iantilipemic iagent? A) iPhotosensitivity. B) iLiver idysfunction. C) iUpper irespiratory iinfections i(URI). D) iWater isoluble ivitamin ideficiencies. i- i i i icorrect ianswer.B) iLiver idysfunction. Feedback: i Antilipemic iagents i(lipid-regulating iagents) iare imetabolized iby ithe iliver iand irequire iregular imonitoring iof iliver ifunction istudies ifor ihepatic idysfunction i(B). iPhotosensitivity i(A), iURI i(C), iand ivitamin ideficiencies i(D) iare inot iside-effects iof iantilipemics. A iclient iwith iAttention iDeficit iDisorder i(ADD) iis iprescribed iamphetamine i(Adderall). iWhich iside ieffect ishould ithe ipractical inurse i(PN) iexplain iis icommonly iexperienced? A) iDifficulty isleeping. B) iIncreased ifatigue. C) iImproved iappetite. D) iDecreased iheart irate. i- i i i icorrect ianswer.A) iDifficulty isleeping. Feedback: i Adderall iis ia icentral inervous isystem istimulant, iwhich ioften icauses ithe iclient ito iexperience idifficulty isleeping i(A). iDue ito icentral inervous istimulation, iAdderall icauses ian iincrease iin ienergy, ia idecrease iin iappetite, iand ian iincrease iin iheart irate, inot i(B, iC, iand iD). An iolder iclient iwho itakes irisperidone i(Risperdal), ian iantipsychotic, iis icomplaining iof iconstipation. iWhich idietary ichanges ishould ithe ipractical inurse i(PN) irecommend? A) iIncrease idaily igreen ivegetables iand ibran. B) iTake ia ilaxative iand istool isoftener idaily. C) iEat iliver iand iturnips ionce ia iweek. D) iUse ia iretention ienema ievery ifour idays. i- i i i icorrect ianswer.A) iIncrease idaily igreen ivegetables iand ibran. Feedback: i Constipation, ia iside ieffect iof iantipsychotics, iis imanaged iby iencouraging ithe iclient ito idrink iadditional iwater iand iincrease idietary iroughage, isuch ias ibran iand igreen ivegetables idaily i(A). i(B, iC, iand iD) iare inot iroutine irecommendations ifor iconstipation. A iclient's itissue iculture iresults iindicate ithe iwound iis iinfected iwith imethicillin-resistant iStaphylococcus iaureus i(MRSA). iWhat iaction ishould ithe ipractical inurse i(PN) iimplement ifirst? A) iProvide isterile iwound icare ias iprescribed. B) iGive ithe ifirst idose iof iVancomycin i(Vancocin). C) iImplement icontact iisolation iprecautions. D) iDocument iwound isite iappearance iand idrainage. i- i i i icorrect ianswer.C) iImplement icontact iisolation iprecautions. Feedback: i The irisk iof itransmitting ia ihospital iacquired iinfectious idisease iamong iclients iis ihigh iwith ian iorganism isuch ias iMRSA. iInfection iprevention iand icontrol ipractices, iincluding icontact iisolation iprecautions, ishould ibe iimplemented ifirst i(C). i(A, iB, iand iD) imay ibe iimplemented iafter iisolation iprecautions iare iin iplace. The ipractical inurse iasks ia imale iclient iwho icame ito ithe iclinic iwith ian iupper irespiratory iinfection iif ihe ihas iany idrug iallergies. iThe iclient icannot iremember iif ihe idoes ior iif ihe iever ireceived ipenicillin. iAfter iadministering ithe iinjection iof ipenicillin, ithe iPN itells ithe iclient ito istay ifor i30 iminutes iof iobservation. iWhich ifinding ishould ithe iPN iidentify ithat iis iindicative iof ia ireaction ito ithe imedication? A) iRash, iitching, iand ihives. B) iFever iand iabdominal ipain. C) iDrop iin itemperature iand iblood ipressure. D) iA ivasovagal iresponse iwith ibradycardia. i- i i i icorrect ianswer.A) iRash, iitching, iand ihives. Feedback: i A iclient iwho iis iunsure iabout ithe iresponse ito ia inew iantibiotic, iespecially ipenicillin, ishould ibe iassessed ifor iallergy ito ithe idrug iafter ireceiving ia iparenteral idose. iThe isymptoms ithat iindicate ian iallergic ireaction iinclude irash, iitching, ihives i(A) iand ianaphylactic ireactions icausing ilaryngeal iedema iwith idifficulty ibreathing. i(B, iC, iand iD) iare inot itypical iof iallergic iresponses ito ipenicillin. A iclient ireceives ia iprescription ifor iclotrimazole i1% i(Gyne-Lotrimin) ivaginal icream ifor iCandidiasis. iWhich iinformation ishould ithe ipractical inurse iprovide ithe iclient? A) iDiscontinue imedication iif imenstruation ibegins. B) iInstill icream iusing ithe iintravaginal iapplicator ieach inight ifor i7 idays. C) iUse idaily idouching ias ipart iof ithe itreatment ifor ivaginal iyeast iinfections. D) iAbstain ifrom isexual iintercourse iuntil itreatment iis icompleted. i- i i i icorrect ianswer.B) iInstill icream iusing ithe iintravaginal iapplicator ieach inight ifor i7 idays. Feedback: i The iintravaginal icream ishould ibe iinstilled ieach inight ifor i7 idays ito icomplete ithe imedication i(B) ieven iif isymptoms iare irelieved. iMedication ishould ibe icontinued iuntil iit iis icompleted, ieven iduring imenstruation i(A). iDouching i(C) iis icontraindicated. iAbstinence i(D) iis inot irequired. A iclient ireceives ia inew iprescription ifor ibeclomethasone i(Beclovent iOral iInhaler). iWhat iinformation ishould ithe ipractical inurse i(PN) ireinforce iwith ithe iclient iabout ithe iuse iof ithis imedication? A) iUse ifor irapid iresults iin iacute iasthmatic iattacks. B) iMost ieffective iin ipreventing iupper irespiratory iinfections. C) iDaily iuse iprovides iprophylaxis iin iasthma imanagement. D) iInhale iwhen iexposed ito iallergens iin ithe ienvironment. i- i i i icorrect ianswer.C) iDaily iuse iprovides iprophylaxis iin iasthma imanagement. Feedback: i Beclovent iOral iInhaler, ian iinhaled iglucocorticoid, iis iused ifor iprophylaxis iin ithe imanagement iof ichronic iasthma i(C) iand ishould ibe iadministered ion ia ifixed ischedule, inot i(D). iInhaled ibeta i2 iagonists, inot ia iglucocorticoid, iwork irapidly iin iacute iasthma iattacks i(A) iprecipitated iby ienvironmental iallergen iexposure i(D). A iclient iwith ituberculosis i(TB) iasks ithe ipractical inurse i(PN) ithe ivalue iof iprescribed imultidrug itherapy. iWhat iexplanation ishould ithe iPN iprovide? A) iRequired ito ieradicate iTB. B) iEnhances ithe ieffect iof ieach idrug. C) iProvides ia ifaster ieffect ithan isingle idrug itherapy. D) iReduces idevelopment iof iTB iresistant idrugs. i- i i i icorrect ianswer.D) iReduces idevelopment iof iTB iresistant idrugs. Feedback: i The iuse iof imultiple imedications ireduces ithe ipossibility iof ithe itubercle ibacilli ibecoming idrug iresistant i(D). i(A, iB, iand iC) iare iincorrect. The ihealthcare iprovider iprescribes ian iantibiotic ifor ia imale iadolescent iwith ian iupper irespiratory itract iinfection iwho iasks ithe ipractical inurse i(PN) ihow ilong ithe iprescribed iantibiotics ishould ibe itaken. iWhat iinformation ishould ithe iPN iprovide? A) iContinue ithe imedication iuntil iall iof ithe iprescription iis itaken. B) iUse ithe imedication ifor i24 ihours iafter ithe icough isubsides. C) iStop ithe imedication iwhen ithe itemperature ireturns ito inormal. D) iTake iany iremaining icapsules iif ithe iinfection ioccurs iagain. i- i i i icorrect ianswer.A) iContinue ithe imedication iuntil iall iof ithe iprescription iis itaken. Feedback: i Although ithe iclient imay ifeel ibetter iafter i24 ihours iof iantibiotics, ithe iprescription i(A) ishould ibe itaken iuntil iall iof iit iis iused. iIf ithe iantibiotic iis idiscontinued ibecause isymptoms ihave idisappeared i(B iand iC), ipathogens ihave ian iopportunity ito iincrease iin ivirulence ior ibecome iresistant ito ithe idrug. iAntibiotics ishould inot ibe isaved i(D) ifor iother iinfections, ibut inew isymptoms ishould ibe ievaluated iby ithe ihealthcare iprovider. A imale iclient itells ithe ipractical inurse i(PN) ithat ihe itakes iacetylsalicylic iacid i(aspirin) i325 img idaily. iWhich ifinding ishould ialert ithe iPN ithat ithe iclient imay ibe iexperiencing ia iside ieffect iof isalicylate itherapy? A) iSkin itears. B) iHypothermia. C) iHepatotoxicity. D) iGastrointestinal idistress. i- i i i icorrect ianswer.D) iGastrointestinal idistress. Feedback: i Salicylates, isuch ias iaspirin, icommonly iirritate ithe igastric imucosa, icausing igastrointestinal idistress i(D). i(A, iB, iand iC) iare iinaccurate. The ihealthcare iprovider iprescribes icelecoxib i(Celebrex), ia inonsteroidal iantiinflammatory idrug i(NSAID), ifor ia iclient iwith iosteoarthritis. iWhich ifinding iin ithe iclient's ihistory ishould ithe ipractical inurse i(PN) ireport? A) iGout. B) iHypertension. C) iDiabetes imellitus. D) iPeptic-ulcer idisease. i- i i i icorrect ianswer.D) iPeptic-ulcer idisease. Feedback: i Celecoxib i(Celebrex), ian iNSAID, icauses igastrointestinal iirritation iand ibleeding. iPeptic-ulcer idisease iis ia icontraindication ito itherapy iwith iNSAIDs i(D). i(A, iB, iand iC) iare iinaccurate. What ilaboratory iresults ishould ithe ipractical inurse imonitor ito ievaluate ithe itherapeutic ieffects iof iheparin? A) iPlatelet icount. B) iHematocrit. C) iProthrombin itime i(PT). D) iActivated ipartial ithromboplastin itime i(APTT). i- i i i icorrect ianswer.D) iActivated ipartial ithromboplastin itime i(APTT). Feedback: i Ongoing iAPTT i(D) ivalues imeasure ithe iprolongation itimes iof ithromboplastin iin ithe iclotting icascade, iwhich iis imonitored iduring iheparin itherapy. i(A, iB, iand iC) ido inot iindicate ithe itherapeutic iaction iof iheparin. Which iinformation ishould ithe ipractical inurse i(PN) iprovide ia iclient iwho ireceives ia inew iprescription ifor ia ibenzodiazepine imedication? A) iA ilist iof ifoods ito iavoid iwhile itaking ithis iprescription. B) iSymptoms ithat iindicate iincreasing ithe idose iof imedication. C) iThe iinteractions iof ialcohol iconsumption iand iCNS idepressant idrugs. D) iExplanations ithat isupport itaking ia iwork iabsence iduring idrug itherapy. i- i i i icorrect ianswer.C) iThe iinteractions iof ialcohol iconsumption iand iCNS idepressant idrugs. Feedback: i The iconcomitant iuse iof ialcohol iand ibenzodiazepines i(C), iboth iCNS idepressants, icauses ian iincrease iin isedation, iwhich iplaces ithe iclient iat irisk ifor iinjury iand ishould ibe iavoided. i(A, iB, iand iD) iare inot iindicated. Which iinformation ishould ithe ipractical inurse i(PN) ireinforce iwith ia iclient iwho iis iself-administering iinsulin iinjections? A) iShake ithe ivial iof iinsulin ito imix ithe icontents ibefore iadministration. B) iStore iopened ivials iof iinsulin iin ia irefrigerator ino imore ithan i30 idays. C) iUse ia idifferent isyringe ito iprepare iand iinject ieach itype iof iinsulin. D) iAspirate iregular iinsulin iin ithe isyringe ifirst iwhen imixing iinsulins. i- i i i icorrect ianswer.D) iAspirate iregular iinsulin iin ithe isyringe ifirst iwhen imixing iinsulins. Feedback: i When iadministering itwo itypes iof iinsulin, ithe iregular iinsulin ishould ibe iprepared ifirst i(D) ito iprevent ithe icontamination iof ithe iregular iinsulin ivial iwith ilong-acting iinsulins. iGently irolling ithe ivial iof iinsulin ibetween ithe ipalms iof ithe ihands iis irecommended, inot i(A). iOpened ivials iof iinsulin ican ibe istored iat iroom itemperature ifor i30 idays iafter ibeing iopened, iand irefrigeration i(B) iis inot inecessary. iDifferent isyringes i(C) iare inot ineeded iwhen iadministering itwo itypes iof iinsulin. What iside ieffect ishould ithe ipractical inurse i(PN) ireport ito ithe ihealthcare iprovider ifor ia iclient iwho iis itaking iprednisone i(Deltasone)? A) iDehydration. B) iHypoglycemia. C) iThickened iskin. D) iGastric ibleeding. i- i i i icorrect ianswer.D) iGastric ibleeding. Feedback: i Prednisone, ia iglucocorticoid, idecreases ithe iviscosity iof igastric imucus, iwhich inormally iprotects ithe ilining iof ithe istomach ifrom iirritants, iwhich iincreases ithe irisk iof igastric ierosion iby ihydrochloric iacid, iresulting iin igastric ibleeding i(D). iOther iadverse ieffects iinclude isodium iand ifluid iretention, ihyperglycemia, iand iskin ifragility, inot i(A, iB, iand iC). What iside ieffect ishould ithe ipractical inurse i(PN) ireport ito ithe ihealthcare iprovider ifor ia iclient iwho iis itaking iprednisone i(Deltasone)? A) iDehydration. Feedback: iINCORRECT B) iHypoglycemia. Feedback: iINCORRECT C) iThickened iskin. Feedback: iINCORRECT D) iGastric ibleeding. Feedback: iCORRECT i- i i i icorrect ianswer.D) iGastric ibleeding. Feedback: i Prednisone, ia iglucocorticoid, idecreases ithe iviscosity iof igastric imucus, iwhich inormally iprotects ithe ilining iof ithe istomach ifrom iirritants, iwhich iincreases ithe irisk iof igastric ierosion iby ihydrochloric iacid, iresulting iin igastric ibleeding i(D). iOther iadverse ieffects iinclude isodium iand ifluid iretention, ihyperglycemia, iand iskin ifragility, inot i(A, iB, iand iC). A imale iclient iwho iis ihypertensive iis istarting ia inew iprescription ifor iclonidine i(Catapress) i0.4 img iPO idaily. iIn ireviewing icommon iside ieffects, iwhat iinformation ishould ithe ipractical inurse i(PN) iprovide ithe iclient? A) iReport iproblems iwith isexual ifunction. B) iMonitor irespirations ion ia idaily ibasis. C) iIncreased ilibido imay ibe iexperienced. D) iWeight igain imay iindicate ifluid iretention. i- i i i icorrect ianswer.A) iReport iproblems iwith isexual ifunction. Feedback: i Sexual idysfunction i(A), isuch ias iimpotence iand idecreased ilibido, iis ia icommon icomplication iof iantihypertensive imedications iin imale iclients. iRespiratory ichanges i(B), iincreased ilibido i(C), iand iincreased iweight i(D) ido inot icommonly ioccur iwith ithis iantihypertensive. A iclient iwho iis ireceiving ian iantibiotic isuddenly idevelops ihives. iThe ipractical inurse ishould ireport ithat ithe iclient iis imost ilikely iexperiencing iwhich itype iof idrug iresponse? A) iAdverse iresponse. B) iHypersensitivity ireaction. C) iIdiosyncratic ireaction. D) iMultiple idrug iinteraction. i- i i i icorrect ianswer.B) iHypersensitivity ireaction. Feedback: i Hives, ia isymptom iof ia ihypersensitivity ireaction i(B), iinvolve ian iabnormal iimmune iresponse iand iare inot iuncommon iwith ithe iuse iof iantibiotics. iAlthough i(A, iC, iand iD) iare iunexpected ipharmacologic ireactions, ihives irepresent ia ilife-threatening iallergic iresponse iand ishould ibe ireported ito iensure iprompt iintervention. The ihealthcare iprovider iprescribes icycloplegic iand imydriatic iophthalmic idrops ifor ia iclient iwho iis ihaving ia icataract iremoval. iWhat iexplanation iabout ithe idrug iactions ishould ithe ipractical inurse i(PN) iprovide ithe iclient? A) iReduces iintraocular ipressure.